0.00Open0.00Pre Close0 Volume0 Open Interest62.00Strike Price0.00Turnover7262.29%IV-19.68%PremiumDec 13, 2024Expiry Date15.19Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9546Delta0.0092Gamma5.31Leverage Ratio-377.3659Theta0.0000Rho5.06Eff Leverage0.0001Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet